Dow Down0.22% Nasdaq Up0.14%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
70.16 Up 0.79(1.14%) Aug 22, 4:00PM EDT
|After Hours : 70.45 Up 0.29 (0.41%) Aug 22, 5:05PM EDT
Company EventsGet Company Events for:
Upcoming Events 
DateEvent
Oct 22 - Oct 27, 2014 (Est.)Earnings announcement
Recent Events 
DateEvent
1-Aug-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement
31-Jul-14BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report
30-Jul-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
10-Jun-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
2-May-14BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report
1-May-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
25-Mar-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
13-Mar-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisi
6-Mar-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S
27-Feb-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
26-Feb-14BIOMARIN PHARMACEUTICAL INC Files SEC form 10-K, Annual Report
18-Feb-14BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Regulation FD Disclosure
23-Dec-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement
6-Dec-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers
28-Oct-13BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report
24-Oct-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
15-Oct-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina
11-Oct-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina
26-Aug-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Unregistered Sale of Equity Securities
29-Jul-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
29-Jul-13BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report
25-Jul-13BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a